1264-Prostate Cancer Neuroendocrine Differentiation

Paper Talk · Jul 11, 2026 · 22m

This manuscript examines the emergence of neuroendocrine differentiation (NED) during the early stages of prostate cancer progression. By utilizing spatial transcriptomics and single-cell RNA sequencing, researchers identified a distinct molecular subtype in hormone-sensitive tissues that predicts a poor clinical prognosis. The study established a six-gene biomarker panel—comprising FMN2, APLP1, SCG2, SCG3, CHGB, and RIMBP2—to effectively identify patients at high risk for treatment resistance. Furthermore, the authors discovered that the Hedgehog signaling pathway specifically drives these…